Home › Funds › HOMESTEAD ADVISERS CORP › RPRX
HOMESTEAD ADVISERS CORP position in RPRX
ROYALTY PHARMA PLC · Health Care
HOMESTEAD ADVISERS CORP reported holding 1,657,242 shares of RPRX (ROYALTY PHARMA PLC) in its Q3 2026 13F filing — a position valued at US$96.7M, representing 2.46% of its reported portfolio and ranking #12 among its reported holdings. HOMESTEAD ADVISERS CORP has disclosed RPRX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How HOMESTEAD ADVISERS CORP's RPRX position evolved
HOMESTEAD ADVISERS CORP first disclosed a stake in RPRX in Q3 2023 at 1,343,040 shares (US$36.5M). The position peaked in Q3 2026 at 1,657,242 shares, worth US$96.7M. Across 13 filings, HOMESTEAD ADVISERS CORP increased the stake 2 time(s), trimmed it 4 time(s) and left it unchanged 6 time(s). The most recent filing (Q3 2026) shows 1,657,242 shares valued at US$96.7M. Notable position changes include a 41% increase in Q1 2024 (shares fell 13% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 1.34M | $36.45M | New |
| Q4 2023 | 1.35M | $37.80M | Hold |
| Q1 2024 | 1.89M | $57.50M | Add |
| Q2 2024 | 1.86M | $49.05M | Reduce |
| Q3 2024 | 1.86M | $52.57M | Hold |
| Q4 2024 | 1.93M | $49.26M | Add |
| Q1 2025 | 1.93M | $60.12M | Hold |
| Q2 2025 | 1.94M | $69.88M | Hold |
| Q3 2025 | 1.90M | $67.12M | Reduce |
| Q4 2025 | 1.67M | $64.59M | Reduce |
| Q1 2026 | 1.65M | $78.91M | Reduce |
| Q2 2026 | 1.66M | $92.92M | Hold |
| Q3 2026 | 1.66M | $96.68M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About RPRX and 13F data
RPRX (ROYALTY PHARMA PLC) is a Health Care company. 47 other funds we track also report a position in RPRX — the largest reported positions include Swedbank AB (US$598.8M), Baillie Gifford & Co (US$534.1M), ROYAL LONDON ASSET MANAGEMENT LTD (US$348.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding RPRX
- Swedbank AB 10.26M sh · $598.81M · Q3 2026
- Baillie Gifford & Co 9.15M sh · $534.11M · Q3 2026
- ROYAL LONDON ASSET MANAGEMENT LTD 5.97M sh · $348.63M · Q3 2026
- Caledonia (Private) Investments Pty Ltd 5.78M sh · $323.85M · Q2 2026
- Patient Capital Management, LLC 3.42M sh · $199.71M · Q3 2026
- Dorsey Asset Management, LLC 2.46M sh · $137.74M · Q2 2026
- Regal Partners Ltd 2.45M sh · $137.25M · Q2 2026
- Clark Capital Management Group, Inc. 1.66M sh · $93.24M · Q2 2026
- NEW SOUTH CAPITAL MANAGEMENT INC 1.45M sh · $84.36M · Q3 2026
More on HOMESTEAD ADVISERS CORP
FAQ
How long has HOMESTEAD ADVISERS CORP held RPRX?
HOMESTEAD ADVISERS CORP has disclosed RPRX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is HOMESTEAD ADVISERS CORP's current position in RPRX?
As of Q3 2026, HOMESTEAD ADVISERS CORP holds 1.66M shares of RPRX (ROYALTY PHARMA PLC), valued at $96.68M, representing 2.46% of its reported portfolio and ranking #12.
Has HOMESTEAD ADVISERS CORP been buying or selling RPRX?
In the latest 13F filing (Q3 2026), HOMESTEAD ADVISERS CORP held unchanged its position in RPRX. The position peaked in Q3 2026 at 1.66M shares.
Which other funds hold RPRX?
Other major institutional holders of RPRX include Swedbank AB, Baillie Gifford & Co, ROYAL LONDON ASSET MANAGEMENT LTD, among 47 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.